Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Geron reported $21K in Sales Revenues for its fiscal quarter ending in March of 2023.

Sales Change
Amgen AMGN:US USD 6.1B 734M
Bio Techne TECH:US USD 294.15M 22.56M
CTI Biopharma CTIC:US USD 24.12M 3.03M
Cytokinetics CYTK:US USD 4.61M 2.66M
Esperion Therapeutics ESPR:US USD 24.33M 5.51M
Exelixis EXEL:US USD 408.79M 15.13M
Genmab GEN:DC DKK 2.85B 2.37B
Geron GERN:US USD 21K 82K
Gilead Sciences GILD:US USD 6.35B 1.04B
Incyte Corp INCY:US USD 808.67M 118.03M
MacroGenics MGNX:US USD 24.5M 48.6M
Novartis NOVN:VX USD 13.21B 207M
Novavax NVAX:US USD 80.95M 276.45M
Seattle Genetics SGEN:US USD 519.72M 8.43M